RDHL Stock Price Chart
RDHL Stock Price Prediction
Redhill Biopharma Ltd
$0.84
-1.75%
$-0.01
At close: Jun 30, 16:00:00 GMT-4
$0.84
0%
$0
Post-market: Jun 30, 20:00:00 GMT-4
Back
Redhill Biopharma Ltd (RDHL) Stock Price Prediction
Key Stats
Prev.Close
$0.8601
Open
$0.8458
Day's Range
$0.845 - $0.89
52 week range
$0.7101 - $3.3
Volume
48.0K
Avg.Volume
57.3K
Dividend yield
--
EPS (TTM)
-0.00
Market Cap
$4.3M
What is RDHL?
RedHill Biopharma Ltd. engages in the development and commercialization of drugs for gastrointestinal (GI), infectious diseases, and oncology. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.
